Showing results (91-100 of 401) with videos related to
Sort By:
Pageof 41
Annals of Translational Medicine|October 27, 2018
Overview of model validation for survival regression model with competing risks using melanoma study dataZhongheng Zhang, Giuliana Cortese, Christophe Combescure, et al.Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|October 29, 2017
Comparison of contact radiographed and stained histological sections for osseointegration analysis of dental implants: an in vivo studyOliver Bissinger, Carolin Götz, Anke Jeschke, et al.Radiology|May 16, 2014
Fluorescence-aided tomographic imaging of synovitis in the human fingerPouyan Mohajerani, Maximilian Koch, Klaus Thürmel, et al.Annals of Translational Medicine|August 25, 2021
Intraoperative completion studies in carotid endarterectomy: systematic review and meta-analysis of techniques and outcomesChristoph Knappich, Thomas Lang, Pavlos Tsantilas, et al.Translational Sports Medicine|April 24, 2024
Feasibility of a 12-Month Exercise Intervention in Postsurgical Colorectal Cancer PatientsMelanie Heitkamp, Bianca Spanier, Pia von Korn, et al.The New England Journal of Medicine|August 18, 2005
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patientsAlban Dibra, Adnan Kastrati, Julinda Mehilli, et al.Journal of the National Cancer Institute|August 7, 2003
Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancerMartin Reck, Joachim von Pawel, Hans-Nicolas Macha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinomaRalf Gertler, Robert Rosenberg, Dominik Stricker, et al.Lung Cancer (Amsterdam, Netherlands)|May 23, 2006
Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trialMartin Reck, Joachim von Pawel, Hans-Nicholas Macha, et al.Critical Care Medicine|October 12, 2022
Preparing for the Worst-Case Scenario in a Pandemic: Intensivists Simulate Prioritization and Triage of Scarce ICU ResourcesKathrin Knochel, Katharina Adaktylos-Surber, Eva-Maria Schmolke, et al.Pageof 41